RegeneRx Announces $1.75 Million Private Placement

ROCKVILLE, Md., June 27, 2016, RGRX, /PRNewswire/ RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ( the Company or RegeneRx ), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that it has entered into a definitive agreement to sell 5,147,059 shares of common stock at a purchase price of $0.34 per share to a dedicated healthcare institutional investor in a private placement. In connection with the offering, the investor will also receive warrants to purchase up to 5,147,059 The post RegeneRx Announces $1.75 Million Private Placement appeared first on Public Wire.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: